The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity
Frontiers in Medicine · 24.06.2025 · 12
DOI: 10.3389/fmed.2025.1577906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 24.06.2025. Verfasst von Douglas A Gaskarth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
CD8+ T cells are vital in the immune control of cancer and a key player in cell-based cancer immunotherapy. Recent studies have shown that microbial short-chain fatty acids (SCFA) can promote both effector and memory phenotypes in CD8+ T cells and may thereby enhance protection against cancer.
Methods
In this study, we determined the effect of SCFA butyrate on mouse CD8+ T cell function in vitro and in vivo , using the OT-I model.
Results
Butyrate co-culture with anti-CD3 + anti-CD28 activated T cells in vitro enhanced the frequency of effector CD8+ IFN-γ-producing cells, and the amount of cytokine produced per cell. Culture with butyrate also enhanced the activation, TCR expression, and levels of phosphorylated mTOR proteins within CD8+ T cells but reduced proliferation rate and increased apoptosis. Butyrate-treated activated cells conferred tumor protection after adoptive transfer. Butyrate-treated cells were present at higher frequencies within the tumor compared to non-butyrate treated cells, and expressed IFN-γ. When analyzed using high dimensional cytometry, the tumors of mice that received butyrate-treated cells were enriched in clusters displaying an effector memory phenotype with high expression of IL-15Rβ and T-bet.
Discussion
Our findings show that butyrate promotes the effector activity of CD8+ T cells in culture, which can persist in vivo while also stimulating memory phenotypes. Consequently, butyrate treatment may have strong application in T cell-based immunotherapies to improve protective cell functions and patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Zitieren
APA
Gaskarth, D. A., Fan, S., Highton, A. J., & Kemp, R. A. (2025). The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1577906
Vancouver
Gaskarth DA, Fan S, Highton AJ, Kemp RA. The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1577906
BibTeX
@article{Gaskarth2025,
author = {Gaskarth, Douglas A and Fan, Shujun and Highton, Andrew J and Kemp, Roslyn A},
title = {The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity},
journal = {Frontiers in Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fmed.2025.1577906}
}
EUVIMED